Page last updated: 2024-08-21

acetylhydrazine and sulindac

acetylhydrazine has been researched along with sulindac in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abulmeaty, M; Afsar, T; Algarni, A; Almajwal, A; Alruwaili, NW; Bhat, MA; Bibi, N; Inam, A; Razak, S; Shabbir, M; Trembley, JH	1

Other Studies

1 other study(ies) available for acetylhydrazine and sulindac

Article	Year
Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways. Scientific reports, 2022, 07-11, Volume: 12, Issue:1 Topics: Antioxidants; Cisplatin; Cyclooxygenase 2; Humans; Hydrazines; Inflammation; Interleukin-1; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha	2022

Article

Year

Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways.

Scientific reports, 2022, 07-11, Volume: 12, Issue:1

Topics: Antioxidants; Cisplatin; Cyclooxygenase 2; Humans; Hydrazines; Inflammation; Interleukin-1; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha

2022